Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3). (Q53669938)

17 May 2018

title

Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3). (English)

1 reference

17 May 2018

main subject

arsenic trioxide

0 references

cervix uterine cancer

1 reference

6

1 reference

17 May 2018

author name string

Yong Jin Chun

1

1 reference

17 May 2018

In Chul Park

2

1 reference

17 May 2018

Myung Jin Park

3

1 reference

17 May 2018

Sang Hyeok Woo

4

1 reference

17 May 2018

Seok Il Hong

5

1 reference

17 May 2018

Tae Hwan Kim

7

1 reference

17 May 2018

Yun Sil Lee

8

1 reference

17 May 2018

Chang Hun Rhee

9

1 reference

17 May 2018

Su Jae Lee

10

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

17 May 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

17 May 2018

volume

519

1 reference

17 May 2018

issue

1-3

1 reference

17 May 2018

page(s)

195-200

1 reference

17 May 2018

Introduction: the history of arsenic trioxide in cancer therapy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902765-5

Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902765-5

Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902765-5

Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902765-5

Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902765-5

In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902765-5

Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902765-5

Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902765-5

In vivo genotoxic effect of arsenic trioxide in mice using comet assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902765-5

Exit from G2 phase after 2 Gy gamma irradiation is faster in radiosensitive human cells with high expression of the RAF1 proto-oncogene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902765-5

10.1016/S0014-5793(02)02765-5

21 January 2018

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018